Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Using dose–response characteristics of therapeutic agents for treatment decisions in type 2 diabetes. Local targets link to admitted publications; unresolved targets remain external evidence.
The sixth report of the Joint National Committee on Prevention, Detection Evaluation and Treatment of High Blood Pressure
10.1001/archinte.1997.00440420033005 · 1997 · External reference
Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
1993 · External reference
10.2337/diacare.21.1.s23
10.2337/diacare.21.1.s23 · External reference
10.2337/diacare.21.1.s36
10.2337/diacare.21.1.s36 · External reference
10.1016/s0140-6736(98)07019-6
10.1016/s0140-6736(98)07019-6 · External reference
10.1016/s0140-6736(98)07037-8
10.1016/s0140-6736(98)07037-8 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.2337/diacare.15.6.737
10.2337/diacare.15.6.737 · External reference
10.1002/dme.1996.13.s6.151
10.1002/dme.1996.13.s6.151 · External reference
Unresolved reference
1994 · External reference
10.7326/0003-4819-124-1_part_2-199601011-00011
10.7326/0003-4819-124-1_part_2-199601011-00011 · External reference
10.1007/bf00579720
10.1007/bf00579720 · External reference
10.1136/bmj.310.6972.83
10.1136/bmj.310.6972.83 · External reference
The relationships between dose and concentration of tolbutamide and insulin and glucose responses in patients with non‐insulin‐dependent diabetes
10.1007/bf00280071 · 1991 · External reference
10.2337/diacare.19.8.849
10.2337/diacare.19.8.849 · External reference
10.2337/diacare.20.4.597
10.2337/diacare.20.4.597 · External reference
10.1007/bf00606420
10.1007/bf00606420 · External reference
10.7326/0003-4819-118-3-199302010-00002
10.7326/0003-4819-118-3-199302010-00002 · External reference
Selective unresponsiveness of pancreatic β‐cells to acute sulfonylurea stimulation during sulfonylurea therapy in NIDDM
10.2337/diab.35.12.1314 · 1986 · External reference
10.1016/s0002-9343(96)00353-1
10.1016/s0002-9343(96)00353-1 · External reference
10.1016/s0149-2918(98)80086-6
10.1016/s0149-2918(98)80086-6 · External reference
10.1111/j.1464-5491.1992.tb01822.x
10.1111/j.1464-5491.1992.tb01822.x · External reference
10.1016/s0002-9343(97)00254-4
10.1016/s0002-9343(97)00254-4 · External reference
10.2337/diacare.16.4.621
10.2337/diacare.16.4.621 · External reference
10.1056/nejm199508313330902
10.1056/nejm199508313330902 · External reference
10.1111/j.1445-5994.1991.tb01375.x
10.1111/j.1445-5994.1991.tb01375.x · External reference
10.2337/diacare.17.10.1100
10.2337/diacare.17.10.1100 · External reference
10.1111/j.1464-5491.1994.tb00253.x
10.1111/j.1464-5491.1994.tb00253.x · External reference
10.2337/diacare.19.1.64
10.2337/diacare.19.1.64 · External reference
Metformin monotherapy for type II diabetes
1998 · External reference
10.1002/j.1875-9114.1997.tb03678.x
10.1002/j.1875-9114.1997.tb03678.x · External reference
10.4158/ep.3.6.359
10.4158/ep.3.6.359 · External reference
10.2337/diacare.21.10.1659
10.2337/diacare.21.10.1659 · External reference
10.2337/diacare.21.10.1587
10.2337/diacare.21.10.1587 · External reference
10.2337/diacare.21.11.2036
10.2337/diacare.21.11.2036 · External reference
10.1210/jc.74.5.1020
10.1210/jc.74.5.1020 · External reference
Oral antidiabetic combination therapy with sulphonylureas and metformin
1991 · External reference
10.1002/j.1875-9114.1996.tb02997.x
10.1002/j.1875-9114.1996.tb02997.x · External reference
10.2337/diacare.18.6.817
10.2337/diacare.18.6.817 · External reference
10.1001/archinte.1994.00420210080009
10.1001/archinte.1994.00420210080009 · External reference
10.2165/00003495-199754010-00010
10.2165/00003495-199754010-00010 · External reference
10.1210/jc.83.9.3169
10.1210/jc.83.9.3169 · External reference
10.1056/nejm199803263381302
10.1056/nejm199803263381302 · External reference
10.7326/0003-4819-128-3-199802010-00002
10.7326/0003-4819-128-3-199802010-00002 · External reference
10.1002/(sici)1096-9136(199809)15:9<772::aid-dia677>3.0.co;2-x
10.1002/(sici)1096-9136(199809)15:9<772::aid-dia677>3.0.co;2-x · External reference
10.1007/bf00418542
10.1007/bf00418542 · External reference
Troglitazone dose–response study in patients with NIDDM
1995 · External reference
10.2165/00002018-199411040-00002
10.2165/00002018-199411040-00002 · External reference
